Results from a mailed promotion of medication reviews among department of defense beneficiaries receiving 10 or more chronic medications

Journal of Managed Care Pharmacy

Volumn 16, Issue 8, 2010, Pages 578-592

  Linton, Andrea ^a,b   Bacon, Thomas A ^c,d   Trice, Shana ^c,d   Devine, Joshua ^e   Cottrell, Linda ^g   McGinnis, Thomas J ^f   McAllister, Everett B ^f  

^a Pharmacy Outcomes Research Team (PORT)   (United States)

^b Pharmacy Outcomes Research Team (PORT)   (United States)

^c PORT   (United States)

^d PORT   (United States)

^e Pharmacoeconomic Center   (United States)

^f Office of the Assistant Secretary of Defense (Health Affairs)   (United States)

^g Kennell and Associates Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG UTILIZATION; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; POLYPHARMACY; PRESCRIPTION;

EID: 77958564909     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2010.16.8.578     Document Type: Article

References (43)

1. Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs. 2005;31(9):4-11.
2. Prybys K, Melville K, Hanna J, Gee A, Chyka P. Polypharmacy in the elderly; clinical challenges in emergency practice: Part 1: overview, etiology, and drug interactions. Emergency Medicine Reports. 2002;23(11):145-53.
3. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556-64. Available at: http://content.nejm. org/cgi/reprint/348/16/1556.pdf. Accessed August 31, 2010. (Pubitemid 36437933)
4. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107-16. Available at: http://jama.ama-assn.org/cgi/reprint/289/9/ 1107. Accessed August 29, 2010.
5. Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med. 2001;38(6):666-71. (Pubitemid 33131567)
6. Fillit HM, Futterman R, Orland BI, et al. Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews. Am J Manag Care. 1999;5(5):587-94. Available at: http://www.ajmc.com/media/pdf/ AJMC1999mayFillet587-594.pdf. Accessed August 29, 2010.
7. zarowitz BJ, Stebelsky LA, Muma BK, Romain TM, Peterson EL. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy. 2005;25(11):1636-45.
8. Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Robert MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol. 2004;58(6):648-64. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884656/. Accessed August 29, 2010.
9. Linton A, Garber M, Fagan NK, Peterson MR. Examination of multiple medication use among TRICARE beneficiaries aged 65 years and older. J Manag Care Pharm. 2007;13(2):155-62. Available at: http://amcp.org/data/jmcp/p155-62.pdf.
10. Trice S, Devine J, Mistry H, Moore E, Linton A. Formulary management in the Department of Defense. J Manag Care Pharm. 2009;15(2):133-46. Available at: http://www.amcp.org/data/jmcp/133-146.pdf.
11. Rask KJ, Wells KJ, Teitel GS, Hawley JN, Richards C, Gazmararian JA. Can an algorithm for appropriate prescribing predict adverse drug events? Am J Manag Care. 2005;11(3):145-51. Available at: http://www.ajmc.com/media/pdf/AJMC- 05mar-Rask-145to151.pdf. Accessed August 29, 2010.
12. Fulda TR, Lyles A, Pugh MC, Christensen DB. Current status of prospective drug utilization review. J Manag Care Pharm. 2004;10(5):433-41. Available at: http://www.amcp.org/data/jmcp/Contemporary%20Subject-433-441.pdf.
13. D'Agostino RB Jr, D'Agostino RB Sr. Estimating treatment effects using observational data. JAMA. 2007;297(3):314-16.
14. Parsons LS. Using SAS® software to perform a case-control match on propensity score in an observational study [Paper 225-25]. Proceedings of the Twenty-Fifth Annual SAS® Users Group International Conference, Cary, NC: SAS Institute, Inc.; 2000. Available at: http://www2.sas.com/proceedings/sugi25/25/ po/25p225.pdf. Accessed August 29, 2010.
15. Linton A, Garber, M, Fagan NK, Peterson M. Factors associated with choice of pharmacy setting among DoD health care beneficiaries aged 65 years or older. J Manag Care Pharm. 2007;13(8):677-86. Available at: http://www.amcp.org/data/ jmcp/JMCPMaga-677-686.pdf. (Pubitemid 350065236)
16. Clark DO, Von Korff M, Saunders K, Baluch WM, Simon GE. A chronic disease score with empirically derived weights. Med Care. 1995;33(8):783-95.
17. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716-24. Available at: http://archinte.ama-assn.org/cgi/reprint/ 163/22/2716. Accessed August 29, 2010.
18. Wickström G, Bendix T. The "Hawthorne effect" - what did the original Hawthorne studies actually show? Scand J Work Environ Health. 2000;26(4):363-67.
19. Kaufman MB, Brodin KA, Sarafian A. Effect of prescriber education on the use of medications contraindicated in older adults in a managed Medicare population. J Manag Care Pharm. 2005;11(3):211-19. Available at: http://www.amcp.org/data/jmcp/Research-211-219.pdf.
20. Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54(10):1516-23. (Pubitemid 44564145)
21. Jaski ME, Schwartzberg JG, Guttman RA, Noorani M. Medication review and documentation in physician office practice. Eff Clin Pract. 2000;3(1):31-34. Available at: http://www.acponline.org/clinical-information/journals- publications/ecp/janfeb00/jaski.htm. Accessed August 29, 2010.
22. Care for Older Adults (COA), HEDIS 2009. Healthcare Effectiveness Data & Information Set. Vol. 2, Technical Specifications. Washington, D.C.: National Committee for Quality Assurance (NCQA); 2008: various p. Available at: http://www.ncqa.org/Portals/0/PublicComment/HEDIS2009/COA-Specs-PDF.pdf. Accessed August 29, 2010.
23. Tarn DM, Paterniti DA, Kravitz RL, Fein S, Wenger NS. How do physicians conduct medication reviews? J Gen Intern Med. 2009;24(12):1296-302. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787945/. Accessed August 29, 2010.
24. Steinman MA, Rosenthal GE, Landefeld CS, Bertenthal D, Kaboli PJ. Agreement between drugs-to-avoid criteria and expert assessments of problematic prescribing. Arch Intern Med. 2009;169(14):1326-32. Available at: http://archinte.ama-assn.org/cgi/content/full/169/14/1326. Accessed August 29, 2010.
25. Jano E, Aparasu RR. Heathcare outcomes associated with Beers' criteria: a systematic review. Ann Pharmacother. 2007;41(3):438-47.
26. Pugh MJ, Hanlon JT, zeber JE, Bierman A, Cornell J, Berlowitz DR. Assessing potentially inappropriate prescribing in the elderly Veterans Affair population using the HEDIS 2006 quality measure. J Manag Care Pharm. 2006;12(7):537-45. Available at: http://amcp.org/data/jmcp/research-537-545.pdf.
27. McMahon FG, Ryan JR, Akdamar K, Ertan A. Effect of potassium chloride supplements on upper gastrointestinal mucosa. Clin Pharmacol Ther. 1984;35(6):852-55. (Pubitemid 14077495)
28. Curtiss FR, Fairman KA. Quality improvement opportunities in prescriber alert programs. J Manag Care Pharm. 2010;16(4):292-96. Available at: http://www.amcp.org/data/jmcp/292-296.pdf.
29. Buck MD. Retrospective monitoring of drug-drug interactions using a CPOE alerting knowledgebase. AMIA Annu Symp Proc. 2007;11:80-84. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2655819/pdf/amia-0080-s2007.pdf. Accessed August 29, 2010.
30. zermansky AG, Petty DR, Raynor DK, Lowe CJ, Freemantle N, Vail A. Clinical medication review by a pharmacist of patients on repeat prescriptions in general practice: a randomised controlled trial. Health Technol Assess. 2002;6(20):1-86. Available at: http://www.hta.ac.uk/fullmono/mon620.pdf. Accessed August 29, 2010.
31. Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2008;65(3):303-16. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC2291244/. Accessed August 29, 2010.
32. Royal S, Smeaton L,Avery AJ, Hurwitz B, Sheikh A. Interventions in primary care to reduce medication-related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care. 2006;15(1):23-31. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC2563996/. Accessed August 29, 2010.
33. Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure. Ann Intern Med. 2007;146(10):714-25. Available at: http://www.annals.org/content/146/10/714.full.pdf+html Accessed August 29, 2010.
34. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296(21):2563-71. Available at: http://jama.ama-assn.org/cgi/reprint/296/21/ 2563. Accessed August 29, 2010.
35. Carter BL, Doucette WR, Franciscus CL, Ardery G, Kluesner KM, Chrschilles EA. Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention. Pharmacotherapy. 2010;30(3):228-35.
36. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008:28(4):421-36.
37. Truong HA, Layson-Wolf C, de Bittner MR, Owen JA, Haupt S. Perceptions of patients on Medicare Part D medication therapy management services. J Am Pharm Assoc (2003). 2009;49(3):392-98.
38. Garcia GM, Snyder ME, McGrath SH, Smith RB, McGivney MS. Generating demand for pharmacist-provided medication therapy management: identifying patient-preferred marketing strategies. J Am Pharm Assoc (2003). 2009;49(5):611-16.
39. Salter C, Holland R, Harvey I, Henwood K. "I haven't even phoned my doctor yet." The advice giving role of the pharmacist during consultations for medication review with patients aged 80 or more: qualitative discourse analysis. BMJ. 2007:334(7603):1101. Available at: http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC1877907/. Accessed August 29, 2010.
40. Alkhateeb FM, Clauson KA, McCafferty R, Latif DA. Physician attitudes toward pharmacist provision of medication therapy managment services. Pharm World Sci. 2009:31(4):487-93.
41. Lounsberry JL, Green CG, Bennett MS, Pedersen CA. Evaluation of pharmacists' barriers to the implementation of medication therapy management services. J Am Pharm Assoc (2003). 2009;49(1):51-58.
42. Blake KB, Madhavan SS, Scott VG, Meredith Elswick BL. Medication therapy management services in West Virgina: pharmacists' perceptions of education and training needs. Res Social Adm Pharm. 2009;5(2):182-88.
43. Herbert KE, Urmie JM, Newland BA, Farris KB. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of explained behavior. Res Social Adm Pharm. 2006;2(3):299-314.